Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...

Eli Lilly and Incyte's Olumiant has secured the first FDA approval for a systemic drug to treat alopecia areata, an autoimmune ... drugs in the class including Pfizer's Xeljanz (tofacitinib ...

Ritlecitinib is under clinical development by Pfizer and currently in Phase II for Keloids ... Litfulo is indicated for the treatment of Alopecia areata for adults and children aged 12 years or older, ...

Financial writer analysis of Arcutis Biotherapeutics, Inc. stock surge and potential growth, FDA approvals, and partnerships in 2025. Click for this ARQT update.

15 new drugs selected for negotiation accounted for $41 billion in Medicare Part D costs between 2023 and 2024. Medicare beneficiaries are projected to save $7.2 billion annually from the $2,000 ...

Fitness. The viral infusion that helps you sleep and is becoming more and more established: it almost always works Fitness. The best fruits to cleanse your liver daily: perfect for after Christmas ...

To learn more about the new drug residue testing requirements and tools that can help you avoid a damaging residue violation, visit www.AvoidResidues.com or contact your veterinarian or Pfizer Animal ...

Hydroxychloroquine is usually tried first, as there are fewer side effects compared to other antimalarial drugs. Cigarette smoking can reduce efficacy, so patients should be encouraged to quit ...

Drug testing may be required as a prerequisite for some jobs. State laws may dictate when private employers can require drug tests and how they can use the results. Job candidates for “safety ...